{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:25:13Z","timestamp":1791923113799,"version":"4.3.4"},"reference-count":116,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T00:00:00Z","timestamp":1690934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Hematological neoplasms sharing a blastic morphology may involve the skin. The skin may be either the primary site of occurrence of hematological malignancies with blastic features or cutaneous lesions are the first manifestation of an underlying systemic malignancy. The assessment of skin biopsies of hematological neoplasms with blastic features poses diagnostic problems and requires expert hematopathologists considering a wide range of differential diagnoses. The precise diagnosis of diseases sharing blastic features but with different outcomes and requiring distinct therapies is essential for patient management. The present paper mainly focuses on cutaneous involvement of the blastoid variant of mantle cell lymphoma and lymphoblastic lymphoma of B-cell or T-cell origin. The relevant literature has been reviewed and the clinical aspects, pathological features, prognosis, and therapy of both blastoid mantle cell lymphoma and lymphoblastic lymphoma involving the skin are discussed. A focus on other hematological entities with blastic features, which may involve the skin, to be taken into consideration in differential diagnosis is also given.<\/jats:p>","DOI":"10.3390\/cancers15153928","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T10:57:33Z","timestamp":1690973853000},"page":"3928","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Skin Involvement by Hematological Neoplasms with Blastic Morphology: Lymphoblastic Lymphoma, Blastoid Variant of Mantle Cell Lymphoma and Differential Diagnoses"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8733-9933","authenticated-orcid":false,"given":"Magda","family":"Zanelli","sequence":"first","affiliation":[{"name":"Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Sanguedolce","sequence":"additional","affiliation":[{"name":"Pathology Unit, Policlinico Riuniti, University of Foggia, 71122 Foggia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9841-7856","authenticated-orcid":false,"given":"Maurizio","family":"Zizzo","sequence":"additional","affiliation":[{"name":"Surgical Oncology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4189-0316","authenticated-orcid":false,"given":"Valentina","family":"Fragliasso","sequence":"additional","affiliation":[{"name":"Laboratory of Translational Research, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2576-6523","authenticated-orcid":false,"given":"Giuseppe","family":"Broggi","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences and Advanced Technologies \u201cG.F. Ingrassia\u201d Anatomic Pathology, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2299-5160","authenticated-orcid":false,"given":"Andrea","family":"Palicelli","sequence":"additional","affiliation":[{"name":"Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6241-1206","authenticated-orcid":false,"given":"Giuseppe Gaetano","family":"Loscocco","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, CRIMM, Center of Research and Innovation of Myeloproliferative Neoplasms, Azienda Ospedaliera-Universitaria Careggi, University of Florence, 50134 Florence, Italy"},{"name":"Doctorate School GenOMec, University of Siena, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9844-4763","authenticated-orcid":false,"given":"Camilla","family":"Cresta","sequence":"additional","affiliation":[{"name":"Pathology Unit, Azienda Ospedaliera Santa Maria di Terni, University of Perugia, 05100 Terni, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Caprera","sequence":"additional","affiliation":[{"name":"Pathology Unit, Azienda Ospedaliera Santa Maria di Terni, University of Perugia, 05100 Terni, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Corsi","sequence":"additional","affiliation":[{"name":"Pathology Unit, Azienda Ospedaliera Santa Maria di Terni, University of Perugia, 05100 Terni, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Martino","sequence":"additional","affiliation":[{"name":"Pathology Unit, Azienda Ospedaliera Santa Maria di Terni, University of Perugia, 05100 Terni, Italy"},{"name":"Hematology, Centro di Ricerca Emato-Oncologica\u2014C.R.E.O., University of Perugia, 06129 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Bisagni","sequence":"additional","affiliation":[{"name":"Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialisa","family":"Marchetti","sequence":"additional","affiliation":[{"name":"Pathology Unit, Azienda USL-IRCCS di Reggio Emilia, 42123 Reggio Emilia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9502-7916","authenticated-orcid":false,"given":"Nektarios","family":"Koufopoulos","sequence":"additional","affiliation":[{"name":"Second Department of Pathology, Medical School, National and Kapodistrian University of Athens, Attikon University Hospital, 15772 Athens, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0591-6723","authenticated-orcid":false,"given":"Paola","family":"Parente","sequence":"additional","affiliation":[{"name":"Pathology Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Foggia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8591-8010","authenticated-orcid":false,"given":"Rosario","family":"Caltabiano","sequence":"additional","affiliation":[{"name":"Department of Medical and Surgical Sciences and Advanced Technologies \u201cG.F. Ingrassia\u201d Anatomic Pathology, University of Catania, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Ascani","sequence":"additional","affiliation":[{"name":"Pathology Unit, Azienda Ospedaliera Santa Maria di Terni, University of Perugia, 05100 Terni, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of Mature Lymphoid Neoplasms: A report from the Clinical Advisory Committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2722","DOI":"10.1182\/blood-2017-08-737502","article-title":"Blastoid and pleomorphic mantle cell lymphoma: Still a diagnostic and therapeutic challenge!","volume":"132","author":"Dreyling","year":"2018","journal-title":"Blood"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2141.2005.05716.x","article-title":"Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): A clinicopathological study from the European MCL Network","volume":"131","author":"Tieman","year":"2005","journal-title":"Br. J. Haematol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/cncy.22077","article-title":"Accuracy of diagnosing mantle cell lymphoma and identifying its variants on fine-needle aspiration biopsy","volume":"127","author":"Foshat","year":"2019","journal-title":"Cancer Cytopathol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/his.12009","article-title":"Variability in morphology and cell proliferation in sequential biopsies of mantle cell lymphoma at diagnosis and relapse: Clinical correlation and insights into disease progression","volume":"62","author":"Vogt","year":"2013","journal-title":"Histopathology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00428-015-1840-6","article-title":"Mantle cell lymphoma\u2014A spectrum from indolent to aggressive disease","volume":"468","author":"Sander","year":"2016","journal-title":"Virchows Arch."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/01.pas.0000128671.92609.af","article-title":"Aberrant Bcl6 Protein Expression in Mantle Cell Lymphoma","volume":"28","author":"Camacho","year":"2004","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1309\/AJCPBV9ELXC0ECVL","article-title":"Differential expression of CD200 in B-cell neoplasms by flow cytometry can assist in diagnosis, subclassification, and bone marrow staging","volume":"142","author":"Challagundla","year":"2014","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3324\/haematol.2009.010264","article-title":"SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype","volume":"94","author":"Mozos","year":"2009","journal-title":"Haematologica"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Lee, W., Shin, E., Kim, B.-H., and Kim, H. (2019). Diagnostic accuracy of SOX11 immunohistochemistry in mantle cell lymphoma: A meta-analysis. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0225096"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.3324\/haematol.2009.008474","article-title":"Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt\u2019s lymphoma","volume":"94","author":"Dictor","year":"2009","journal-title":"Haematologica"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1182\/blood-2005-04-1753","article-title":"Cyclin D1-negative mantle cell lymphoma: A clinicopathologic study based on gene expression profiling","volume":"106","author":"Fu","year":"2005","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood-2012-08-452284","article-title":"CCND2 rearrangements are the most frequent genetic events in cyclin D1\u2212 mantle cell lymphoma","volume":"121","author":"Salaverria","year":"2013","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1200\/JCO.2015.63.8387","article-title":"Faculty Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network","volume":"34","author":"Hoster","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.hoc.2020.06.009","article-title":"Blastoid Mantle Cell Lymphoma","volume":"34","author":"Jain","year":"2020","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11912-018-0728-4","article-title":"Toward a Risk-Tailored Therapeutic Policy in Mantle Cell Lymphoma","volume":"20","author":"Condoluci","year":"2018","journal-title":"Curr. Oncol. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1182\/blood-2017-07-797019","article-title":"Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network","volume":"131","author":"Aukema","year":"2018","journal-title":"Blood"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1182\/bloodadvances.2019001396","article-title":"Genomic profiles and clinical outcomes of de novo blastoid\/pleomorphic MCL are distinct from those of transformed MCL","volume":"4","author":"Jain","year":"2020","journal-title":"Blood Adv."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3109\/10428194.2015.1094801","article-title":"Clinicopathologic features, management and outcomes of blastoid variant of mantle cell lymphoma: A Nebraska Lymphoma Study Group Experience","volume":"57","author":"Bhatt","year":"2016","journal-title":"Leuk. Lymphoma"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.3109\/10428194.2015.1026902","article-title":"Clinicopathologic features and management of blastoid variant of mantle cell lymphoma","volume":"56","author":"Shrestha","year":"2015","journal-title":"Leuk. Lymphoma"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1600-0609.2005.00409.x","article-title":"Blastoid variant of mantle cell lymphoma: Late progression from classical mantle cell lymphoma and quantitation of minimal residual disease","volume":"74","author":"Pott","year":"2005","journal-title":"Eur. J. Haematol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1097\/PAS.0000000000001312","article-title":"Mantle cell lymphoma involving skin: A clinicopathologic study of 37 cases","volume":"43","author":"Kim","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1309\/TE56-A43X-29TT-5H8G","article-title":"CD5-mantle cell lymphoma","volume":"118","author":"Liu","year":"2002","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1097\/PAS.0000000000001278","article-title":"CD5-negative mantle cell lymphoma: Clinicopathologic correlations and outcome in 58 patients","volume":"43","author":"Miao","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1365-2559.2008.03060.x","article-title":"Mantle cell lymphoma with aberrant expression of CD10","volume":"53","author":"Zanetto","year":"2008","journal-title":"Histopathology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/PAS.0000000000000758","article-title":"Mantle cell lymphoma with MYC rearrangement: A report of 17 patients","volume":"41","author":"Hu","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/gcc.22123","article-title":"Complex karyotype in mantle cell lymphoma is a strong prognostic factor for the time to treatment and overall survival, independent of the MCL international prognostic index","volume":"53","author":"Sarkozy","year":"2014","journal-title":"Genes Chromosom. Cancer"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/ajh.25487","article-title":"Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management","volume":"94","author":"Jain","year":"2019","journal-title":"Am. J. Hematol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/PAS.0000000000000445","article-title":"Skin involvement of mantle cell lymphoma may mimic primary cutaneous diffuse large B-cell lymphoma, leg type","volume":"39","author":"Wehkamp","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1097\/00000478-200210000-00008","article-title":"Mantle cell lymphoma involving skin: Cutaneous lesions may be the first manifestation of disease and tumors often have blastoid cytologic features","volume":"26","author":"Sen","year":"2002","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1034\/j.1600-0560.2001.028005256.x","article-title":"Cutaneous lymphocyte-associated antigen (CLA) expression in a lymphoblastoid mantle cell lymphoma presenting with skin lesions. Comparison with other clinicopathologic presentations of mantle cell lymphoma","volume":"28","author":"Campo","year":"2001","journal-title":"J. Cutan. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1600-0560.2011.01832.x","article-title":"Primary cutaneous mantle cell lymphoma with blastic features: Report of a rare case with special reference to staging and effectiveness of chemotherapy","volume":"39","author":"Lynch","year":"2012","journal-title":"J. Cutan. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2340\/00015555-0886","article-title":"Cutaneous presentation of mantle cell lymphoma","volume":"90","author":"Canpolat","year":"2010","journal-title":"Acta Derm. Venereol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0190-9622(94)70002-8","article-title":"Mantle zone lymphoma: An immunohistologic study of skin lesions","volume":"30","author":"Bertero","year":"1994","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2340\/00015555-1084","article-title":"Primary Cutaneous Mantle Cell Lymphoma","volume":"91","author":"Alaibac","year":"2011","journal-title":"Acta Derm. Venereol."},{"key":"ref_37","first-page":"394596","article-title":"Primary Cutaneous Mantle Cell Lymphoma: A Case Report","volume":"2013","author":"Mazzuoccolo","year":"2013","journal-title":"Case Rep. Dermatol. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1097\/DAD.0b013e31828bc7ac","article-title":"Primary cutaneous mantle cell lymphoma of the leg with blastoid morphology and aberrant immunophenotype: A diagnostic challenge","volume":"36","author":"Cesinaro","year":"2014","journal-title":"Am. J. Dermatopathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/cup.12802","article-title":"Cutaneous mantle cell lymphoma: A clinicopathologic review of 10 cases","volume":"43","author":"Gru","year":"2016","journal-title":"J. Cutan. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/DAD.0000000000001742","article-title":"Cutaneous Involvement by Mantle Cell Lymphoma: Expanding the Spectrum of Histopathologic Findings in a Series of 9 Cases","volume":"42","author":"Panse","year":"2020","journal-title":"Am. J. Dermatopathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/DAD.0b013e31819d845a","article-title":"Primary cutaneous blastoid mantle cell lymphoma-case report","volume":"31","author":"Estrozi","year":"2009","journal-title":"Am. J. Dermatopathol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1200\/JCO.2012.47.2829","article-title":"Primary Cutaneous Mantle-Cell Lymphoma: A Case Report and Literature Review","volume":"33","author":"Hamad","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13045-020-00905-2","article-title":"Evolving therapy of adult acute lymphoblastic leukemia: State-of-the-art treatment and future directions","volume":"13","author":"Samra","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3282","DOI":"10.1200\/JCO.20.00256","article-title":"Children\u2019s Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia","volume":"38","author":"Dunsmore","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/path.1126","article-title":"Immunohistochemical detection of CD79a expression in precursor T cell lymphoblastic lymphoma\/leukaemias","volume":"197","author":"Hashimoto","year":"2002","journal-title":"J. Pathol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/bjh.12042","article-title":"The immunophenotype of T-lymphoblastic lymphoma in children and adolescents: A Children\u2019s Oncology Group report","volume":"159","author":"Patel","year":"2012","journal-title":"Br. J. Haematol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Zanelli, M., Loscocco, G.G., Sabattini, E., Zizzo, M., Sanguedolce, F., Panico, L., Fanni, D., Santi, R., Caprera, C., and Rossi, C. (2021). T-Cell Lymphoblastic Lymphoma Arising in the Setting of Myeloid\/Lymphoid Neoplasms with Eosinophilia: LMO2 Immunohistochemistry as a Potentially Useful Diagnostic Marker. Cancers, 13.","DOI":"10.3390\/cancers13123102"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jaad.2013.10.020","article-title":"Precursor B- or T-lymphoblastic lymphoma presenting with cutaneous involvement: A series of 13 cases including 7 cases of cutaneous T-lymphoblastic lymphoma","volume":"70","author":"Lee","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1525-1470.2005.22105.x","article-title":"Concurrent Mycosis Fungoides and Precursor B Cell Lymphoblastic Lymphoma in a 6-Year-Old Child","volume":"22","author":"Chou","year":"2005","journal-title":"Pediatr. Dermatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000081275","article-title":"Very Late Central Nervous System Relapse in a Patient with B Cell Lymphoblastic Lymphoma","volume":"112","author":"Nagasaki","year":"2004","journal-title":"Acta Haematol."},{"key":"ref_51","first-page":"193","article-title":"Primary cutaneous pre-B lymphoblastic lymphoma immunohistologically mimics Ewing\u2019s sarcoma\/primitive neuroectodermal tumor","volume":"102","author":"Hsiao","year":"2003","journal-title":"J. Formos. Med. Assoc."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10024-001-0104-4","article-title":"Cutaneous Lymphoblastic Lymphoma in Children: Report of Six Cases with Precursor B-cell Lineage","volume":"5","author":"Kahwash","year":"2002","journal-title":"Pediatr. Dev. Pathol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1309\/Q5GV-3K00-WAC6-BBUB","article-title":"Precursor B-cell lymphoblastic lymphoma: A study of nine cases lacking blood and bone marrow involvement and review of the literature","volume":"115","author":"Maitra","year":"2001","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1097\/00000478-200011000-00003","article-title":"Precursor B-cell lymphoblastic lymphoma: A predominantly extranodal tumor with low propensity for leukemic involvement","volume":"24","author":"Lin","year":"2000","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1600-0560.1999.tb01861.x","article-title":"Cutaneous involvement in lymphoblastic lymphoma","volume":"26","author":"Chimenti","year":"1999","journal-title":"J. Cutan. Pathol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1542\/peds.100.1.60","article-title":"Cutaneous involvement in children with acute lymphoblastic leukemia or lymphoblastic lymphoma: The children\u2019s leukemia cooperative group of the European Organization of Research and Treatment of Cancer (EORTC)","volume":"100","author":"Millot","year":"1997","journal-title":"Pediatrics"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000245966","article-title":"Lymphoblastic Lymphoma of the Pre-B Phenotype with Cutaneous Presentation","volume":"195","author":"Schmitt","year":"1997","journal-title":"Dermatology"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0190-9622(91)70302-I","article-title":"Lymphoblastic lymphoma presenting in cutaneous sites: A clinicopathologic analysis of six cases","volume":"25","author":"Sander","year":"1991","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/1097-0142(19880115)61:2<303::AID-CNCR2820610220>3.0.CO;2-3","article-title":"B-cell differentiation pattern of cutaneous lymphomas in infancy and childhood","volume":"61","author":"Ladenstein","year":"1988","journal-title":"Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1182\/blood.V61.5.838.838","article-title":"Cutaneous lymphoblastic lymphoma with pre-B markers","volume":"61","author":"Link","year":"1983","journal-title":"Blood"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/mpo.2950120407","article-title":"Pre-B cell cutaneous lymphoma in infancy: A unique clinical entity","volume":"12","author":"Meyers","year":"1984","journal-title":"Med. Pediatr. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1182\/blood.V59.3.549.549","article-title":"Non-T, non-B lymphomas are rare in childhood and associated with cutaneous tumor","volume":"59","author":"Bernard","year":"1982","journal-title":"Blood"},{"key":"ref_63","first-page":"997","article-title":"A novel pediatric case of cutaneous pre-B lymphoblastic lymphoma","volume":"86","author":"Biasotti","year":"2001","journal-title":"Haematologica"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1182\/blood.V62.2.464.464","article-title":"The immunologic and clinicopathologic heterogeneity of cutaneous lymphomas other than mycosis fungoides","volume":"62","author":"Wood","year":"1983","journal-title":"Blood"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1034\/j.1600-0560.2001.290208.x","article-title":"Primary cutaneous lymphoblastic lymphoma presenting in an 8-week old infant","volume":"29","author":"Trupiano","year":"2002","journal-title":"J. Cutan. Pathol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/00313020902756246","article-title":"Primary cutaneous lymphoblastic lymphoma in children: Series of eight cases with review of the literature","volume":"41","author":"Muljono","year":"2009","journal-title":"Pathology"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2340\/00015555-0702","article-title":"Precursor B-cell Lymphoblastic Lymphoma with only Cutaneous Involvement","volume":"89","author":"Kawakami","year":"2009","journal-title":"Acta Derm. Venereol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/DAD.0000000000001347","article-title":"Cutaneous B-Cell Lymphoblastic Lymphoma","volume":"41","author":"Amarasekera","year":"2019","journal-title":"Am. J. Dermatopathol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jaad.2010.10.040","article-title":"Cutaneous B-cell lymphoblastic lymphoma in children: A rare diagnosis","volume":"66","author":"Boccara","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2141.2010.08541.x","article-title":"Clinical presen- tation, evolution, and prognosis of precursor B-cell lym- phoblastic lymphoma in trials LMT96, EORTC 58881, and EORTC 58951","volume":"152","author":"Ducassou","year":"2011","journal-title":"Br. J. Haematol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"652","DOI":"10.4103\/0378-6323.45116","article-title":"Primary cutaneous B-cell lymphoblastic lymphoma","volume":"74","author":"Gupta","year":"2008","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/ced.12658","article-title":"Primary cutaneous pre- cursor B cell lymphoblastic lymphoma in a child, complicated by fatal disseminated varicella zoster virus","volume":"40","author":"Rashidghamat","year":"2015","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1111\/pde.13169","article-title":"Primary Cutaneous B-Cell Lymphoblastic Lymphoma Arising from a Long-Standing Lesion in a Child and Review of the Literature","volume":"34","author":"Song","year":"2017","journal-title":"Pediatr. Dermatol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.0736-8046.2004.21500.x","article-title":"The Spectrum of Cutaneous Lymphomas in Patients Less than 20 Years of Age","volume":"21","author":"Chott","year":"2004","journal-title":"Pediatr. Dermatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1080\/10428190601059712","article-title":"Unusual presentation of precursor T-cell lymphoblastic lymphoma: Involvement limited to breasts and skin","volume":"48","author":"Gallagher","year":"2007","journal-title":"Leuk. Lymphoma"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12288-010-0007-5","article-title":"T lymphoblastic lymphoma relapsing in skin\u2014A rare clinical scenario","volume":"26","author":"Prasad","year":"2010","journal-title":"Indian J. Hematol. Blood Transfus."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.3109\/10428194.2011.618233","article-title":"Three cases of primary cutaneous lymphoblastic lymphoma: Microarray-based comparative genomic hybridization and gene expression profiling studies with review of literature","volume":"53","author":"Vezzoli","year":"2012","journal-title":"Leuk. Lymphoma"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.annder.2017.01.001","article-title":"Cutaneous involvement in T-lymphoblastic lymphoma","volume":"144","author":"Nascimbeni","year":"2017","journal-title":"Ann. Dermatol. Venereol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/cup.13431","article-title":"Cutaneous involvement as the first manifestation of T-lymphoblastic lymphoma and review of the literature","volume":"46","author":"Capusan","year":"2019","journal-title":"J. Cutan. Pathol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1684\/ejd.2020.3772","article-title":"Erythematous cutaneous macules: An uncommon, challenging presentation of T-lymphoblastic lymphoma","volume":"30","author":"Zanelli","year":"2020","journal-title":"Eur. J. Dermatol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1200\/JCO.2017.77.3648","article-title":"New Approaches to the Management of Adult Acute Lymphoblastic Leukemia","volume":"36","author":"Bassan","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jaad.2020.01.058","article-title":"Outcome and clinicophenotypical features of acute lymphoblastic leukemia\/lymphoblastic lymphoma with cutaneous involvement: A multicenter case series","volume":"83","author":"Bontoux","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12308-014-0229-9","article-title":"B-lymphoblastic transformation of mantle cell lymphoma\/leukemia with \u201cdouble hit\u201d changes","volume":"8","author":"Kallen","year":"2015","journal-title":"J. Hematopath."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"200313","DOI":"10.1016\/j.ehpc.2019.200313","article-title":"Blastic transformation of mantle cell lymphoma with B-lymphoblastic features","volume":"17","author":"Cantu","year":"2019","journal-title":"Hum. Pathol. Case Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00428-021-03022-8","article-title":"Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features","volume":"479","author":"Aukema","year":"2021","journal-title":"Virchows Arch."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Cerroni, L. (2020). Skin Lymphoma: The illustrated Guide, Wiley-Backwell. [5th ed.].","DOI":"10.1002\/9781119485933"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/cncr.28664","article-title":"Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: A report from the International DLBCL Rituximab-CHOP Consortium Program","volume":"120","author":"Ok","year":"2014","journal-title":"Cancer"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.3390\/curroncol29050246","article-title":"Cutaneous Involvement in Diseases with Plasma Cell Differentiation: Diagnostic Approach","volume":"29","author":"Zanelli","year":"2022","journal-title":"Curr. Oncol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/j.seminoncol.2016.02.017","article-title":"Cutaneous manifestations of multiple myeloma and other plasma cell proliferative disorders","volume":"43","author":"Bhutani","year":"2016","journal-title":"Semin. Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archderm.1991.01680010079012","article-title":"Cutaneous Manifestations of Multiple Myeloma","volume":"127","author":"Kois","year":"1991","journal-title":"Arch. Dermatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1001\/archderm.139.4.475","article-title":"Cutaneous involvement in multiple myeloma. A clinicopathologic, immunohistochemical ad cytogenetic study of 8 cases","volume":"139","author":"Requena","year":"2003","journal-title":"Arch. Dermatol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.jaad.2017.08.054","article-title":"Prevalence and clinicopathologic characteristics of multiple myeloma with cutaneous involvement: A case series from Korea","volume":"78","author":"Woo","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.3109\/10428194.2015.1128542","article-title":"Cutaneous involvement in multiple myeloma: A multi-institutional retrospective study of 53 patients","volume":"57","author":"Jurczyszyn","year":"2016","journal-title":"Leuk. Lymphoma"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.jaad.2015.12.028","article-title":"Cutaneous involvement in multiple myeloma (MM): A case series with clinicopathologic correlation","volume":"74","author":"Malysz","year":"2016","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s12185-016-2104-1","article-title":"Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: How do myeloma cells escape from the bone marrow to the skin?","volume":"105","author":"Marchica","year":"2017","journal-title":"Int. J. Hematol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/cup.13486","article-title":"Cutaneous localization of plasmablastic multiple myeloma with heterotopic expression of CD3 and CD4: Skin involvement revealing systemic disease","volume":"46","author":"Varricchio","year":"2019","journal-title":"J. Cutan. Pathol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","article-title":"Plasmablastic lymphomas of the oral cavity: A new entity associated with the human immunodeficiency virus infection","volume":"89","author":"Delecluse","year":"1997","journal-title":"Blood"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e22335","DOI":"10.1097\/MD.0000000000022335","article-title":"Oral plasmablastic lymphoma: A case report","volume":"99","author":"Zizzo","year":"2020","journal-title":"Medicine"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1182\/blood-2014-10-567479","article-title":"The biology and treatment of plasmablastic lymphoma","volume":"125","author":"Castillo","year":"2015","journal-title":"Blood"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/PAS.0000000000000234","article-title":"Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent and posttransplant patients single-center series of 25 cases and meta-analysis of 277 reported cases","volume":"38","author":"Morscio","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.5858\/arpa.2016-0232-RA","article-title":"Plasmablastic Lymphoma: A Review of Clinicopathologic Features and Differential Diagnosis","volume":"140","author":"Harmon","year":"2016","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Zanelli, M., Sanguedolce, F., Palicelli, A., Zizzo, M., Martino, G., Caprera, C., Fragliasso, V., Soriano, A., Valle, L., and Ricci, S. (2021). EBV-driven lymphoproliferative disorders and lymphomas of the gastrointestinal tract: A spectrum of entities with a common denominator (Part 2). Cancers, 13.","DOI":"10.3390\/cancers13184527"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"152973","DOI":"10.1016\/j.prp.2020.152973","article-title":"Clinical, pathological and molecular features of plasmablastic lymphoma arising in the gastrointestinal tract: A review and reappraisal","volume":"216","author":"Sanguedolce","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2147\/BLCTT.S142814","article-title":"Plasmablastic lymphoma: Current perspectives","volume":"8","author":"Lopez","year":"2018","journal-title":"Blood Lymphat. Cancer: Targets Ther."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2559.2005.01985.x","article-title":"Plasmablastic lymphoma arising at a cutaneous site","volume":"46","author":"Jordan","year":"2005","journal-title":"Histopathology"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1016\/j.jaad.2012.02.021","article-title":"Primary cutaneous plasmablastic lymphoma of the lower leg in an HIV-negative patient","volume":"67","author":"Heiser","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaad.2007.08.009","article-title":"Cutaneous plasmablastic lymphoma","volume":"58","author":"Jambusaria","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_108","first-page":"541783","article-title":"Cutaneous plasmablastic lymphoma in an immunocompetent patient with long-term pyrimethamine use for essential thrombocytemia: A case report and literature review","volume":"2013","author":"Tiong","year":"2013","journal-title":"Case Rep. Hematol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/10245332.2017.1333275","article-title":"Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: A single institution experience over 13 years","volume":"23","author":"Kaur","year":"2018","journal-title":"Hematology"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s00277-023-05288-1","article-title":"Myeloid sarcoma: More and less than a distinct entity","volume":"102","author":"Loscocco","year":"2023","journal-title":"Ann. Hematol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1746-1596-2-42","article-title":"Myeloid sarcomas: A histologic, immunohistochemical, and cytogenetic study","volume":"2","author":"Alexiev","year":"2007","journal-title":"Diagn. Pathol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/sj.leu.2404491","article-title":"Myeloid sarcoma: Clinico-pathologic, phenotypic and cytogenetic analysis of 92 adult patients","volume":"21","author":"Pileri","year":"2007","journal-title":"Leukemia"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1182\/bloodadvances.2020002474","article-title":"Blastic plasmacytoid dendritic cell neoplasms: Results of an international survey on 398 adult patients","volume":"4","author":"Laribi","year":"2020","journal-title":"Blood Adv."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.3324\/haematol.2010.026179","article-title":"Blastic plasmacytoid dendritic cell neoplasm in children: Diagnostic features and clinical implications","volume":"95","author":"Jegalian","year":"2010","journal-title":"Haematologica"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s12185-020-03070-x","article-title":"Pediatric blastic plasmacytoid dendritic cell neoplasm: Report of four cases and review of literature","volume":"113","author":"Liao","year":"2021","journal-title":"Int. J. Hematol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/ajh.25109","article-title":"A case of disseminated blastic plasmocytoid dendritic cell neoplasm","volume":"93","author":"Loscocco","year":"2018","journal-title":"Am. J. Hematol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/15\/3928\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:24:19Z","timestamp":1760127859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/15\/15\/3928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,2]]},"references-count":116,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["cancers15153928"],"URL":"https:\/\/doi.org\/10.3390\/cancers15153928","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,2]]}}}